ASX:CPH Creso Pharma (CPH) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock Analysis About Creso Pharma Stock (ASX:CPH) 30 days 90 days 365 days Advanced Chart Ad Wide Moat ResearchDonald Trump can’t save you from this crisisElon Musk: “This Is The Most Destructive Force In History” Elon Musk claims a terrifying new economic force will put millions of Americans out of work. The ripple effects could nudge the US economy into a catastrophic tailspin. If this happens, you need to be prepared. That’s why a former Trump advisor is sharing his contingency plan with the public. What is Musk talking about?Get the full details now. Get Creso Pharma alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewCreso Pharma Limited develops, registers, and commercializes pharmaceutical-grade cannabis, and hemp-based nutraceutical products and treatments for human and animal health in Europe, the Middle East, North America, and the Asia Pacific. The company develops and commercializes therapeutic products; and cultivates, processes, and sells cannabis products, as well as supplies cannabis retail products. Its products include anibidiol, a complementary feed product for companion animals; cannaQIX, a nutraceutical product containing hemp oil extract, and vitamins and zinc that reduces stress and supports psychological and nervous functions; and topical and skin care products, which include cannaDOL, a CBD-based topical gel associated with a mixture of cooling and warming essential oils. Creso Pharma Limited was incorporated in 2015 and is headquartered in Nedlands, Australia.Read More… Donald Trump can’t save you from this crisis (Ad)Elon Musk: “This Is The Most Destructive Force In History” Elon Musk claims a terrifying new economic force will put millions of Americans out of work. The ripple effects could nudge the US economy into a catastrophic tailspin. If this happens, you need to be prepared. That’s why a former Trump advisor is sharing his contingency plan with the public. What is Musk talking about?Get the full details now. Receive CPH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Creso Pharma and its competitors with MarketBeat's FREE daily newsletter. Email Address CPH Stock News HeadlinesCipher Pharmaceuticals Announces Q3 2024 Financial ResultsNovember 5, 2024 | markets.businessinsider.comCreso Pharma subsidiary Mernova Medicinal appoints consultant to expedite cannabis exports to Australia and EuropeJune 5, 2023 | msn.com[Charles Payne Live Event] Click to Confirm Your RSVPThe Blueprint to Protect Your Portfolio Charles Payne reveals a strategy few investors know about November 22, 2024 | Unstoppable Prosperity (Ad)Creso Pharma Insiders Lose Out As Stock Sinks To AU$0.009May 25, 2023 | hk.finance.yahoo.comCreso Pharma Insiders Lose Out As Stock Sinks To AU$0.009 \May 25, 2023 | finance.yahoo.comCreso Pharma raises A$2.5 million, streamlines balance sheet for growth strategyMay 19, 2023 | proactiveinvestors.comCreso’s US subsidiary Sierra Sage Herbs signs deal with Groupon; significantly increases potential market sizeMay 9, 2023 | msn.comCreso Pharma gains Supreme Court green light for Health House acquisitionMay 7, 2023 | proactiveinvestors.comSee More Headlines CPH Stock Analysis - Frequently Asked Questions What other stocks do shareholders of Creso Pharma own? Based on aggregate information from My MarketBeat watchlists, some other companies that Creso Pharma investors own include Evolution Mining (EVN), Skin Elements (SKN), Santos (STO), Aurizon (AZJ), C29 Metals (C29), CIMIC Group (CIM) and CSL (CSL). Industry, Sector and Symbol Stock ExchangeASX SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A Current SymbolASX:CPH CUSIPN/A CIKN/A Webwww.cresopharma.com Phone61 2 8067 8606FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)A($0.02) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-32,780,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-130.99% Return on Assets-35.93% Debt Debt-to-Equity Ratio29.92 Current Ratio0.76 Quick Ratio1.41 Sales & Book Value Annual Sales$8.92 million Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book ValueA$0.01 per share Price / BookN/AMiscellaneous Outstanding Shares2,570,000,000Free FloatN/AMarket CapN/A OptionableNot Optionable Beta2.62 5G Stocks: The Path Forward is ProfitableClick the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report This page (ASX:CPH) was last updated on 11/22/2024 by MarketBeat.com Staff From Our Partners[Urgent] Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it a...Paradigm Press | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredThe #1 Bitcoin ETF For Monthly DividendsYou don't have to own any Bitcoin to collect BIG dividends from it... Now, thanks to this brand new Bitcoin...Investors Alley | Sponsored“Trump Trades” You’ve Got to MakeThese Stocks are the Best “Trump Trades” Free e-book reveals sectors – and stocks within them – likely to p...StockEarnings | SponsoredThe AI Crash Begins November 30thMost AI stocks are doomed. I’m not an AI hater. AI will absolutely continue to be the most disruptive tech...Brownstone Research | SponsoredFormer Trump advisor releases terrifying warningGoldman Sachs: 300 Million People Are At Risk The mainstream media are practically ignoring the most import...Wide Moat Research | SponsoredThe Biggest Post-Election Market Shift Ever?Our No. 1 stock for the rare "millionaire window" opening NOW According to Wall Street legend Whitney Tilso...Stansberry Research | SponsoredTrump Won, But Can He Save Your 401(k)?Trump Won, But Your Savings Are Still In Danger It's the ONLY playbook that shows you how to fortify your f...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Creso Pharma Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Creso Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.